MoneyWorks4Me

SPARC eligible to get $5 million upon achieving regulatory milestones

13 Jan 2022 Evaluate

Sun Pharma Advanced Research Company (SPARC) is eligible to receive $5 million upon achieving the regulatory milestones for the program developed using SPARC technology. Pursuant to the agreement entered between the parties, SPARC shall also be eligible for additional future milestones and royalties on net sales.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Peers
Company Name CMP
Sagility 45.94
Prime Focus 352.35
Knowledge RealtyTrt. 113.71
Indegene 596.10
Syngene Internatl. 385.35
View more..